Global Markets
Roche’s (ROG SW) breast cancer pill Wilserdly wins US regulatory approval, Bloomberg reports
ORIGINAL · NewsquawkRoche’s (ROG SW) breast cancer pill Wilserdly wins US regulatory approval, Bloomberg reports
StockNow breaking-news AI analysis
Bloomberg reports that Roche’s breast cancer pill Wilserdly has received US regulatory approval.
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
